Home  >  Products  >  SUCLG2 (succinate-CoA ligase, GDP-forming, beta subunit ) Blocking Peptide (the C terminal of SUCLG2)(100ug)
SUCLG2 (succinate-CoA ligase, GDP-forming, beta subunit ) Blocking Peptide (the C terminal of SUCLG2)(100ug)

SUCLG2 (succinate-CoA ligase, GDP-forming, beta subunit ) Blocking Peptide (the C terminal of SUCLG2)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-SUCLG2 Antibody (ARP66958_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP66958
Size: 100ug
Weight: 48kDa
Gene: 8801
Format: Lyophilized powder
Target: This gene encodes a GTP-specific beta subunit of succinyl-CoA synthetase. Succinyl-CoA synthetase catalyzes the reversible reaction involving the formation of succinyl-CoA and succinate. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 5 and 12.
Alternative names: G-BETA